Ledger.Open graph →
SEC Form D · filed November 1, 2022

LB PHARMACEUTICALS INC

Offering
$10.0M
Sold
$6.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Vincent Grattan · New York, NYDirectorZachary Prensky · New York, NYExec · DirectorMarc Panoff · New York, NYExecEdmund Sullivan · New York, NYDirectorPiero Poli · New York, NYDirectorRobert Ruffolo · New York, NYDirectorVincenzo O. Laruffa · New York, NYExecScjp, Ltd · GRAND CAYMAN, Cayman IslandsDirectorRei Goffer · Boston, MAExec · DirectorMPG Asset Management, LLC · Murphy, TXDirectorChris Cheever · Boston, MADirectorRichard Boyle · Boston, MADirectorJohn F. Arrillaga Jr · New York, NYExec · DirectorWendy F. Abels Eisenberg · New York, NYDirectorDouglas F. Eisenberg · New York, NYDirectorLynne L. Segall · Beverly Hills, CAExecKeaton Cristobal · Garrison, NYDirectorAndrew Chomer · Garrison, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗